Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations

English version České info

Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. To investigate the polygenetic basis of serum uric acid levels, we conducted a meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent, resulting in identification of 954 SNPs distributed across nine loci that exceeded the threshold of genome-wide significance, five of which are novel. Overall, the common variants associated with serum uric acid levels fall in the following nine regions: SLC2A9 (p = 5.2×10⁻²⁰¹), ABCG2 (p = 3.1×10⁻²⁶), SLC17A1 (p = 3.0×10⁻¹⁴), SLC22A11 (p = 6.7×10⁻¹⁴), SLC22A12 (p = 2.0×10⁻⁹), SLC16A9 (p = 1.1×10⁻⁸), GCKR (p = 1.4×10⁻⁹), LRRC16A (p = 8.5×10⁻⁹), and near PDZK1 (p = 2.7×10⁻⁹). Identified variants were analyzed for gender differences. We found that the minor allele for rs734553 in SLC2A9 has greater influence in lowering uric acid levels in women and the minor allele of rs2231142 in ABCG2 elevates uric acid levels more strongly in men compared to women. To further characterize the identified variants, we analyzed their association with a panel of metabolites. rs12356193 within SLC16A9 was associated with DL-carnitine (p = 4.0×10⁻²⁶) and propionyl-L-carnitine (p = 5.0×10⁻⁸) concentrations, which in turn were associated with serum UA levels (p = 1.4×10⁻⁵⁷ and p = 8.1×10⁻⁵⁴, respectively), forming a triangle between SNP, metabolites, and UA levels. Taken together, these associations highlight additional pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia. In addition, these findings strongly support the hypothesis that transport proteins are key in regulating serum uric acid levels.

Vyšlo v časopise: Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations. PLoS Genet 5(6): e32767. doi:10.1371/journal.pgen.1000504
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000504

Souhrn

Zdroje

1. TaniguchiA

KamataniN

2008 Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20 192 197

2. KoenigW

MeisingerC

2008 Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis? Clin Chem 54 231 233

3. HaydenMR

TyagiSC

2004 Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 1 10

4. CutlerRG

1984 Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 3 321 348

5. WhitfieldJB

MartinNG

1983 Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet Med Gemellol (Roma ) 32 117 126

6. DoringA

GiegerC

MehtaD

GohlkeH

ProkischH

2008 SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40 430 436

7. LiS

SannaS

MaschioA

BusoneroF

UsalaG

2007 The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 3 e194 doi:10.1371/journal.pgen.0030194

8. VitartV

RudanI

HaywardC

GrayNK

FloydJ

2008 SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40 437 442

9. WallaceC

NewhouseSJ

BraundP

ZhangF

TobinM

2008 Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82 139 149

10. CaulfieldMJ

MunroePB

O'NeillD

WitkowskaK

CharcharFJ

2008 SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5 e197 doi:10.1371/journal.pmed.0050197

11. DehghanA

KottgenA

YangQ

HwangSJ

KaoWL

2008 Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372 1953 1961

12. SparsoT

AndersenG

NielsenT

BurgdorfKS

GjesingAP

2008 The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51 70 75

13. AnzaiN

MiyazakiH

NoshiroR

KhamdangS

ChairoungduaA

2004 The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem 279 45942 45950

14. HalestrapAP

PriceNT

1999 The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343 Pt 2 281 299

15. HalestrapAP

MeredithD

2004 The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447 619 628

16. SaxenaR

VoightBF

LyssenkoV

BurttNP

de BakkerPI

2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 1331 1336

17. VaxillaireM

Cavalcanti-ProencaC

DechaumeA

TichetJ

MarreM

2008 The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57 2253 2257

18. Orho-MelanderM

MelanderO

GuiducciC

Perez-MartinezP

CorellaD

2008 Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57 3112 3121

19. Ter MaatenJC

VoorburgA

HeineRJ

Ter WeePM

DonkerAJ

1997 Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 92 51 58

20. FacchiniF

ChenYD

HollenbeckCB

ReavenGM

1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266 3008 3011

21. ChoiHK

MountDB

ReginatoAM

2005 Pathogenesis of gout. Ann Intern Med 143 499 516

22. BakkerSJ

GansRO

Ter MaatenJC

TeerlinkT

WesterhoffHV

2001 The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 155 283 290

23. YangC

PringM

WearMA

HuangM

CooperJA

2005 Mammalian CARMIL inhibits actin filament capping by capping protein. Dev Cell 9 209 221

24. SkovhusKV

BergholdtR

ErichsenC

SparreT

NerupJ

2006 Identification and characterization of secretagogin promoter activity. Scand J Immunol 64 639 645

25. EnomotoA

KimuraH

ChairoungduaA

ShigetaY

JutabhaP

2002 Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417 447 452

26. AnzaiN

EnomotoA

EndouH

2005 Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep 7 227 234

27. EkaratanawongS

AnzaiN

JutabhaP

MiyazakiH

NoshiroR

2004 Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 94 297 304

28. AnzaiN

KanaiY

EndouH

2007 New insights into renal transport of urate. Curr Opin Rheumatol 19 151 157

29. GiegerC

GeistlingerL

AltmaierE

HrabedA

KronenbergF

2008 Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4 e1000282 doi:10.1371/journal.pgen.1000282

30. NozakiS

TanakaM

MizunoK

AtakaS

MizumaH

2009 Mental and physical fatigue-related biochemical alterations. Nutrition 25 51 57

31. NakazonoK

WatanabeN

MatsunoK

SasakiJ

SatoT

1991 Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88 10045 10048

32. RauchovaH

DobesovaZ

DrahotaZ

ZichaJ

KunesJ

1998 The effect of chronic L-carnitine treatment on blood pressure and plasma lipids in spontaneously hypertensive rats. Eur J Pharmacol 342 235 239

33. HuangW

ShaikhSN

GanapathyME

HopferU

LeibachFH

1999 Carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells. Biochem Pharmacol 58 1361 1370

34. RoschingerW

MuntauAC

DuranM

DorlandL

IJlstL

2000 Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. Clin Chim Acta 298 55 68

35. LootsDT

MienieLJ

BerghJJ

Van der SchyfCJ

2004 Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat. Life Sci 75 1243 1253

36. StapletonSR

CurrieKP

ScottRH

BellBA

1992 Palmitoyl-DL-carnitine has calcium-dependent effects on cultured neurones from rat dorsal root ganglia. Br J Pharmacol 107 1192 1197

37. FredrikssonR

NordstromKJ

StephanssonO

HagglundMG

SchiothHB

2008 The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett 582 3811 3816

38. LiY